ABOUT US
Investment Professionals with an Edge
Our exclusive focus on healthcare, combined with the proprietary insights of MEDACorp, enables Leerink Swann's analysts to identify agenda-setting investment issues and opportunities in stocks, sectors or therapeutic areas. With one of the largest healthcare research teams on Wall Street, our analysts are constantly working to deliver leading-edge research for clients seeking success in healthcare investing.
The industry expertise of our analysts is enhanced by the healthcare knowledge of our MEDACorp network. The expert, practical insights of MEDACorp's over 25,000 members provide the foundation for much of our proprietary and potentially agenda-setting equity research.
Leerink Swann analysts cover:
- Biotechnology
- Pharmaceuticals, Major
- Pharmaceuticals, Specialty
- Medical Supplies and Devices
- Health Care Facilities & Services
- Health Care Technology & Distribution
- Life Science Tools and Consumables